Cost-effectiveness of Favipiravir in moderately to severely ill COVID-19 patients in the real-world setting of Saudi arabian pandemic referral hospitals()

PURPOSE: We aimed to evaluate the cost effectiveness of Favipiravir treatment versus standard of care (SC) in moderately to severely ill COVID-19 patients from the Saudi healthcare payer perspective. METHODS: We used the patient-level simulation method to simulate a cohort of 415 patients with moder...

Descripción completa

Detalles Bibliográficos
Autores principales: Alamer, Ahmad, Almutairi, Abdulaali R., Halloush, Shiraz, Al-jedai, Ahmed, Alrashed, Ahmed, AlFaifi, Mashael, Mohzari, Yahya, Almutairi, Malak, AlHassar, Fatimah, Howaidi, Jude, Almutairi, Wedad, Abraham, Ivo, Alkhatib, Nimer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930375/
https://www.ncbi.nlm.nih.gov/pubmed/36819111
http://dx.doi.org/10.1016/j.jsps.2023.02.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930375/
https://www.ncbi.nlm.nih.gov/pubmed/36819111
http://dx.doi.org/10.1016/j.jsps.2023.02.003

Ejemplares similares